ABBV FCF Margin
Free cash flow as a percentage of revenue, showing how much of each sales dollar becomes cash.
FCF Margin
Latest: 18.3% (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 43.5% |
| 2020Q4 | 33.0% |
| 2021Q1 | 36.0% |
| 2021Q2 | 33.6% |
| 2021Q3 | 53.8% |
| 2021Q4 | 32.8% |
| 2022Q1 | 35.1% |
| 2022Q2 | 33.3% |
| 2022Q3 | 50.1% |
| 2022Q4 | 47.7% |
| 2023Q1 | 32.9% |
| 2023Q2 | 44.3% |
| 2023Q3 | 52.8% |
| 2023Q4 | 31.8% |
| 2024Q1 | 31.3% |
| 2024Q2 | 14.0% |
| 2024Q3 | 35.9% |
| 2024Q4 | 44.7% |
| 2025Q1 | 10.5% |
| 2025Q2 | 31.7% |
| 2025Q3 | 42.1% |
| 2025Q4 | 29.4% |
| 2026Q1 | 23.8% |
| 2026Q2 | 18.3% |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest FCF Margin: 18.3% (2026Q2); −13.3 pp YoY.
Across the 54 quarters from 2013Q1 to 2026Q2, FCF Margin ranged from -13.4% in 2014Q4 to 53.8% in 2021Q3.
Chart and table show the latest 24 of 54 quarters.